GHSR - growth hormone secretagogue receptor Gene
Species: Canis lupus familiaris (sub-species: familiaris)
Gene Type: protein coding
Gene ID: 100101479
About GHSR
Primary_assembly 34: 36,774,740-36,779,009 reverse strand.ROS_Cfam_1.0:CM025133.1
This gene has 1 transcript (splice variant), 218 orthologues and 15 paralogues.
GHSR Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001099945.1 | NP_001093415.1 | growth hormone secretagogue receptor type 1 |
| NM_001099945.1 | NP_001093415.1 | growth hormone secretagogue receptor type 1 |
GHSR Protein Structure
7tm_GPCRs
7tm_GPCRs: cl28897 (27 - 316)
7tm_GPCRs
7tm_GPCRs: cd14964 (28 - 52)
7tm_GPCRs
7tm_GPCRs: cd14964 (61 - 82)
7tm_GPCRs
7tm_GPCRs: cd14964 (99 - 121)
7tm_GPCRs
7tm_GPCRs: cd14964 (144 - 160)
7tm_GPCRs
7tm_GPCRs: cd14964 (192 - 215)
7tm_GPCRs
7tm_GPCRs: cd14964 (244 - 266)
7tm_GPCRs
7tm_GPCRs: cd14964 (284 - 309)
- 0
- 100
- 200
- 300
- 349 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
growth hormone secretagogue receptor type 1 |
|
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(5)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-14734 | Anamorelin | Agonist | 99.94% | Unkown |
| HY-14734A | Anamorelin hydrochloride | Agonist | 99.59% | Unkown |
| HY-14820A | Macimorelin acetate | Agonist | 99.34% | Yes |
| HY-14820 | Macimorelin | Agonist | / | Unkown |
| HY-14734B | Anamorelin Fumarate | Agonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(8)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase
|
|---|---|---|---|---|
| HY-19884B | Relamorelin TFA | Agonist | 99.16% | Phase 3 |
| HY-14903 | Ulimorelin | Agonist | 96.10% | Phase 3 |
| HY-19884A | Relamorelin acetate | Agonist | / | Phase 3 |
| HY-19884 | Relamorelin | Agonist | / | Phase 3 |
| HY-50844 | Ibutamoren Mesylate | Agonist | 99.86% | Phase 2 |
| HY-12584 | PF-5190457 | Inhibitor | 99.26% | Phase 2 |
| HY-10199A | Ibutamoren | Agonist | 99.84% | Phase 2 |
| HY-P0231 | AZP-531 | 99.36% | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(57)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P5645 | LEAP-2 | Antagonist | 97.75% | Unkown |
| HY-U00433 | JMV 2959 | Antagonist | 99.91% | Unkown |
| HY-13964A | YIL781 hydrochloride | Antagonist | 99.48% | Unkown |
| HY-15243 | Capromorelin Tartrate | Agonist | 98.10% | Unkown |
| HY-P1366 | des-Gln14-Ghrelin | 98.21% | Unkown | |
| HY-P10283 | S1H | Antagonist | 99.32% | Unkown |
| HY-13964 | YIL781 | Antagonist | 99.68% | Unkown |
| HY-171962A | KARI 201 hydrochloride | Agonist | 99.94% | Unkown |
| HY-U00433A | JMV 2959 hydrochloride | Antagonist | 98.09% | Unkown |
| HY-P1155 | GRF (1-29) amide (rat) | Inducer | 99.80% | Unkown |
| HY-P1139 | Cortistatin-8 | Antagonist | 99.56% | Unkown |
| HY-P1421 | Obestatin(human) | Inhibitor | 99.74% | Unkown |
| HY-50760 | L-692585 | Agonist | 98.94% | Unkown |
| HY-N12348 | Emoghrelin | Activator | 95.46% | Unkown |
| HY-116625 | PF-04628935 | Antagonist | 99.58% | Unkown |
| HY-12584A | (S)-PF-5190457 | 99.27% | Unkown | |
| HY-P4750 | Acetyl-(D-Arg2)-GRF (1-29) amide (human) | Antagonist | 99.67% | Unkown |
| HY-113906A | (αR,8aS)-GSK1614343 | Control | 99.72% | Unkown |
| HY-P3596A | GHRF, mouse TFA | Agonist | 98.87% | Unkown |
| HY-P4405 | (D-Ala2)-GRF (1-29) amide (human) | Agonist | 98.83% | Unkown |
| HY-10957 | L-692429 | Agonist | 99.90% | Unkown |
| HY-P1547 | Somatostatin-25 | Inhibitor | 96.77% | Unkown |
| HY-119125 | BMS-317180 | Agonist | / | Unkown |
| HY-P3596 | GHRF, mouse | / | Unkown | |
| HY-157556 | BPP-2 | / | Unkown | |
| HY-176995 | AZ-GHS-38 | Agonist | / | Unkown |
| HY-100305 | Substituted piperidines-1 | Agonist | / | Unkown |
| HY-137061 | AZ-GHS-22 | Antagonist | / | Unkown |
| HY-153095A | PF-6870961 hydrochloride | Agonist | / | Unkown |
| HY-14495B | BMS-604992 dihydrochloride | Agonist | / | Unkown |
| HY-14495A | BMS-604992 free base | Agonist | / | Unkown |
| HY-P1432A | K-(D-1-Nal)-FwLL-NH2 TFA | Antagonist | / | Unkown |
| HY-P10964 | Tezusomant | Antagonist | / | Unkown |
| HY-115272 | GSK894490A | Agonist | / | Unkown |
| HY-153095 | PF-6870961 | Agonist | / | Unkown |
| HY-P1306 | Obestatin(rat) | 98.73% | Unkown | |
| HY-15242 | Capromorelin | Activator | / | Unkown |
| HY-145364 | Ghrelin receptor full agonist-2 | Agonist | / | Unkown |
| HY-19454 | CP-464709 | Agonist | / | Unkown |
| HY-P1432 | K-(D-1-Nal)-FwLL-NH2 | Antagonist | / | Unkown |
| HY-118995 | L-739943 | Activator | / | Unkown |
| HY-186165 | KARI 101 | Agonist | / | Unkown |
| HY-P1366A | des-Gln14-Ghrelin TFA | / | Unkown | |
| HY-171962 | KARI 201 | Agonist | / | Unkown |
| HY-P3607 | GHRF, bovine | Activator | / | Unkown |
| HY-113906 | GSK1614343 | Antagonist | / | Unkown |
| HY-14495 | BMS-604992 | Agonist | / | Unkown |
| HY-P3056 | GHRF, ovine | / | Unkown | |
| HY-117584 | L-163255 free base | / | Unkown | |
| HY-P1306A | Obestatin(rat) TFA | / | Unkown | |
| HY-10957A | L-692429 hydrochloride | Agonist | / | Unkown |
| HY-180210 | Ghrelin receptor full agonist-3 | Agonist | / | Unkown |
| HY-116959 | SM-130686 | / | Unkown | |
| HY-129287 | JMV 3008 | Antagonist | / | Unkown |
| HY-111232 | GSK894281 | Agonist | / | Unkown |
| HY-173271 | GHSR-1a agonist-1 | Agonist | / | Unkown |
| HY-P10673 | KwFwLL-NH2 | Antagonist | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service